Quantum Helium Limited
25 August 2026
25 August 2026
Quantum Helium Limited
("Quantum" or the "Company")
Investor Presentation
Quantum Helium Limited (AIM: QHE) announces that an updated Investor Presentation is now available on the Company's website, providing an overview of Quantum's Colorado helium and oil portfolio, recent progress at Sagebrush and the Company's strategy for the next phase of development, including the planned larger stimulation and testing programme at Sagebrush-1, which is being defined to increase reservoir contact and improve flow performance.
The updated Investor Presentation can be accessed using the following link: www.quantum-helium.com/documents/corporate-presentation-aug-2026/
Enquiries:
|
Quantum Helium Limited Carl Dumbrell Chairman |
NOMAD and Joint Broker SP Angel Corporate Finance LLP Stuart Gledhill / Richard Hail / Adam Cowl +44 (0) 20 3470 0470 |
|
Brand Communications Alan Green Tel: +44 (0) 7976 431608 |
Joint Broker CMC Markets UK Plc Douglas Crippen +44 (0) 020 3003 8632 Joint Broker OAK Securities Jerry Keen / Robert Bell Tel: +44(0) 203 973 3678 |
Updates on the Company's activities are regularly posted on its website: www.quantum-helium.com
Notes to editors
Quantum (AIM: QHE) is a helium, hydrogen and hydrocarbon exploration, development, and production company with projects in the US and Australia. Quantum's strategic objectives remain consistent: to identify opportunities which will provide operating cash flow and have development upside, in conjunction with progressing exploration. The Company has several projects in the US, in addition to royalty interests in Australia.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.